A Systematic Review and Meta-Analysis of Human Milk Feeding and Morbidity in Very Low Birth Weight Infants
by
Jacqueline Miller 1,2,†
, Emma Tonkin 2,†, Raechel A. Damarell 2, Andrew J. McPhee 1,3, Machiko Suganuma 1, Hiroki Suganuma 1, Philippa F. Middleton 1,4, Maria Makrides 1,4 and Carmel T. Collins 1,4,*
Jacqueline Miller 1,2,†, Emma Tonkin 2,†, Raechel A. Damarell 2, Andrew J. McPhee 1,3, Machiko Suganuma 1, Hiroki Suganuma 1, Philippa F. Middleton 1,4, Maria Makrides 1,4 and Carmel T. Collins 1,4,*
1
Healthy Mothers, Babies and Children, South Australian Health and Medical Research Institute, Adelaide, SA 5006, Australia
2
Nutrition and Dietetics, Flinders University, Adelaide, SA 5001, Australia
3
Neonatal Medicine, Women’s and Children’s Hospital, Adelaide, SA 5006, Australia
4
Adelaide Medical School, Discipline of Paediatrics, The University of Adelaide, Adelaide, SA 5006, Australia
*
Author to whom correspondence should be addressed.
†
These authors contributed equally to this work.
Nutrients 2018, 10(6), 707; https://doi.org/10.3390/nu10060707
Received: 24 April 2018 / Revised: 25 May 2018 / Accepted: 29 May 2018 / Published: 31 May 2018
(This article belongs to the Special Issue Early Life Nutrition: From Nutrients to Systems)
This systematic review and meta-analysis synthesised the post-1990 literature examining the effect of human milk on morbidity, specifically necrotising enterocolitis (NEC), late onset sepsis (LOS), retinopathy of prematurity (ROP), bronchopulmonary dysplasia (BPD) and neurodevelopment in infants born ≤28 weeks’ gestation and/or publications with reported infant mean birth weight of ≤1500 g. Online databases including Medline, PubMed, CINAHL, Scopus, and the Cochrane Central Register of Controlled Trials were searched, and comparisons were grouped as follows: exclusive human milk (EHM) versus exclusive preterm formula (EPTF), any human milk (HM) versus EPTF, higher versus lower dose HM, and unpasteurised versus pasteurised HM. Experimental and observational studies were pooled separately in meta-analyses. Risk of bias was assessed for each individual study and the GRADE system used to judge the certainty of the findings. Forty-nine studies (with 56 reports) were included, of which 44 could be included in meta-analyses. HM provided a clear protective effect against NEC, with an approximate 4% reduction in incidence. HM also provided a possible reduction in LOS, severe ROP and severe NEC. Particularly for NEC, any volume of HM is better than EPTF, and the higher the dose the greater the protection. Evidence regarding pasteurisation is inconclusive, but it appears to have no effect on some outcomes. Improving the intake of mother’s own milk (MOM) and/or donor HM results in small improvements in morbidity in this population.
View Full-Text
Keywords:
preterm infant; human milk; necrotising enterocolitis; sepsis; bronchopulmonary dysplasia; retinopathy of prematurity; neurodevelopment; donor human milk; formula feeding
▼
Show Figures
Figure 1
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited
MDPI and ACS Style
Miller, J.; Tonkin, E.; Damarell, R.A.; McPhee, A.J.; Suganuma, M.; Suganuma, H.; Middleton, P.F.; Makrides, M.; Collins, C.T. A Systematic Review and Meta-Analysis of Human Milk Feeding and Morbidity in Very Low Birth Weight Infants. Nutrients 2018, 10, 707.
Show more citation formats
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.
- Supplementary File 1:
PDF-Document (PDF, 694 KB)
